[Statins Use in Elderly Patients]. / Place des statines chez le sujet âgé.
Therapie
; 2015 Nov 02.
Article
en Fr
| MEDLINE
| ID: mdl-26524698
The risk of cardiovascular disease in elderly is significantly higher than in young subjects; paradoxically some treatments that have proven their efficacy in reducing cardiovascular risk are often under prescribed in this age group. The benefits of statins in secondary cardiovascular prevention are well established in patients <80 years. In primary prevention, these drugs reduce the risk of myocardial infarction and stroke, but their effects on cardiovascular mortality remain uncertain. In very elderly patients, there are no randomized trials relative to the impact of statins on morbi-mortality in primary prevention as well in secondary prevention. Adverse effects in the elderly seem to be statistically similar to those occurring in young people , but the prescription in very old people should be individualized, taking into account the life expectancy, the life quality, the comorbidities, and especially the risk of drug interactions.
Buscar en Google
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
Fr
Revista:
Therapie
Año:
2015
Tipo del documento:
Article
País de afiliación:
Túnez